My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 236

    1.

    Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy.

    Roestenberg P, van Nieuwenhoven FA, Wieten L, Boer P, Diekman T, Tiller AM, Wiersinga WM, Oliver N, Usinger W, Weitz S, Schlingemann RO, Goldschmeding R.

    Diabetes Care. 2004 May;27(5):1164-70.PMID: 15111539 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy.

    Nguyen TQ, Tarnow L, Andersen S, Hovind P, Parving HH, Goldschmeding R, van Nieuwenhoven FA.

    Diabetes Care. 2006 Jan;29(1):83-8.PMID: 16373901 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy.

    Nguyen TQ, Tarnow L, Jorsal A, Oliver N, Roestenberg P, Ito Y, Parving HH, Rossing P, van Nieuwenhoven FA, Goldschmeding R.

    Diabetes Care. 2008 Jun;31(6):1177-82. Epub 2008 Mar 14.PMID: 18344285 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes.

    Jaffa AA, Usinger WR, McHenry MB, Jaffa MA, Lipstiz SR, Lackland D, Lopes-Virella M, Luttrell LM, Wilson PW; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Group.

    J Clin Endocrinol Metab. 2008 May;93(5):1893-900. Epub 2008 Mar 4.PMID: 18319310 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy.

    Andersen S, van Nieuwenhoven FA, Tarnow L, Rossing P, Rossing K, Wieten L, Goldschmeding R, Parving HH.

    Kidney Int. 2005 Jun;67(6):2325-9.PMID: 15882275 [PubMed - indexed for MEDLINE]Related articles

    6.

    Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.

    Thomson SE, McLennan SV, Kirwan PD, Heffernan SJ, Hennessy A, Yue DK, Twigg SM.

    J Diabetes Complications. 2008 Jul-Aug;22(4):284-94. Epub 2008 Apr 16.PMID: 18413184 [PubMed - indexed for MEDLINE]Related articles

    7.

    Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy.

    Gilbert RE, Akdeniz A, Weitz S, Usinger WR, Molineaux C, Jones SE, Langham RG, Jerums G.

    Diabetes Care. 2003 Sep;26(9):2632-6.PMID: 12941731 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.

    Roestenberg P, van Nieuwenhoven FA, Joles JA, Trischberger C, Martens PP, Oliver N, Aten J, Höppener JW, Goldschmeding R.

    Am J Physiol Renal Physiol. 2006 Jun;290(6):F1344-54. Epub 2005 Dec 27.PMID: 16380465 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma.

    Dziadzio M, Usinger W, Leask A, Abraham D, Black CM, Denton C, Stratton R.

    QJM. 2005 Jul;98(7):485-92. Epub 2005 Jun 13.PMID: 15955800 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.

    Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM.

    Diabetologia. 2005 Dec;48(12):2650-60. Epub 2005 Nov 4.PMID: 16270194 [PubMed - indexed for MEDLINE]Related articles

    11.

    Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy.

    Adler SG, Kang SW, Feld S, Cha DR, Barba L, Striker L, Striker G, Riser BL, LaPage J, Nast CC.

    Kidney Int. 2001 Dec;60(6):2330-6. Erratum in: Kidney Int 2002 Mar;61(3):1197. PMID: 11737607 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.

    Guha M, Xu ZG, Tung D, Lanting L, Natarajan R.

    FASEB J. 2007 Oct;21(12):3355-68. Epub 2007 Jun 6.PMID: 17554073 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure.

    Koitabashi N, Arai M, Niwano K, Watanabe A, Endoh M, Suguta M, Yokoyama T, Tada H, Toyama T, Adachi H, Naito S, Oshima S, Nishida T, Kubota S, Takigawa M, Kurabayashi M.

    Eur J Heart Fail. 2008 Apr;10(4):373-9. Epub 2008 Mar 11.PMID: 18337169 [PubMed - indexed for MEDLINE]Related articles

    14.

    Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report.

    Riser BL, Cortes P, DeNichilo M, Deshmukh PV, Chahal PS, Mohammed AK, Yee J, Kahkonen D.

    Kidney Int. 2003 Aug;64(2):451-8.PMID: 12846740 [PubMed - indexed for MEDLINE]Related articles

    15.

    Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy.

    Hinton DR, Spee C, He S, Weitz S, Usinger W, LaBree L, Oliver N, Lim JI.

    Diabetes Care. 2004 Mar;27(3):758-64.PMID: 14988298 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Plasma vascular endothelial growth factor in Japanese Type 2 diabetic patients with and without nephropathy.

    Shimada K, Baba T, Neugebauer S, Onozaki A, Yamada D, Midorikawa S, Sato W, Watanabe T.

    J Diabetes Complications. 2002 Nov-Dec;16(6):386-90.PMID: 12477622 [PubMed - indexed for MEDLINE]Related articles

    17.

    Mechanisms through which bradykinin promotes glomerular injury in diabetes.

    Tan Y, Wang B, Keum JS, Jaffa AA.

    Am J Physiol Renal Physiol. 2005 Mar;288(3):F483-92.PMID: 15692059 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.

    Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.

    Diabetes Care. 2004 Mar;27(3):765-9.PMID: 14988299 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.

    Schalkwijk CG, Ligtvoet N, Twaalfhoven H, Jager A, Blaauwgeers HG, Schlingemann RO, Tarnow L, Parving HH, Stehouwer CD, van Hinsbergh VW.

    Diabetes. 1999 Dec;48(12):2446-53.PMID: 10580435 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.

    Hovind P, Tarnow L, Oestergaard PB, Parving HH.

    Kidney Int Suppl. 2000 Apr;75:S56-61.PMID: 10828763 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity